Lv11
50 积分 2022-11-04 加入
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials
1小时前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
3天前
已完结
Prevalence by therapy line and incidence of breast cancer brain metastases in 18,075 patients
14天前
已完结
A real-world study on the safety of the extended dosing schedule for nivolumab and pembrolizumab in patients with solid tumors
1个月前
已完结
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer
8个月前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
9个月前
已完结
Different dosage forms of GnRHa with endocrine therapy in premenopausal hormone Receptor-Positive breast cancer
10个月前
已完结
Validation of a predictive modeling approach to demonstrate the relative efficacy of three different schedules of the AKT inhibitor AZD5363
1年前
已完结
Repair of Topoisomerase I‐Mediated DNA Damage
1年前
已完结
中国男性乳腺癌临床诊治实践指南(2023版)
1年前
已完结
皖公网安备34019202002308
